Skip to content

Cerebellar RTMS in Patients with Multiple Sclerosis

Effect of Cerebellar Repetitive Transcranial Magnetic Stimulation on Coordination in Patients with Multiple Sclerosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06265922
Enrollment
30
Registered
2024-02-20
Start date
2024-02-18
Completion date
2024-08-05
Last updated
2025-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with Multiple Sclerosis

Keywords

Patients with Multiple Sclerosis, Coordination, Transcranial magnetic stimulation

Brief summary

To determine the efficacy of high frequency cerebellar repetitive transcranial magnetic stimulation on coordination in patients with multiple sclerosis.

Detailed description

Forty patients with multiple sclerosis suffering from ataxia less than five in EDSS score will be recruited from the outpatient clinic at Faculty of Physical Therapy as well as Kasr Al-Ainy Multiple Sclerosis unit (KAMSU), Cairo University. The study will be applied during the remission period. Patients will be assessed by Biodex balance system, Berg balance scale, Four square step test and Nine-Hole Peg Test to investigate coordination in both equilibrium and non-equilibrium. Patient will be divided into two groups.The study group will be treated by High frequecy cerebellar repetitive transcranial magnetic stimulation besides a tailored physiotherapy program, while the control group will be treated by Sham cerebellar repetitive transcranial magnetic stimulation with a tailored physiotherapy program as well. The treatment duration for each patient will take weeks.

Interventions

High frequency repetitive transcranial magnetic stimulation will be applied over mid line of cerebellum using circular coil. Ten repetition rate (frequency) in 40 trains with one intertrain interval will be applied for three times a week for two weeks.

DEVICESham repetitive transcranial magnetic stimulation

Sham repetitive transcranial magnetic stimulation will be applied Perpendicular away from the cerebellum using the same circular coil. The same parameters will be used with the same duration also numbers of sessions are the same like the active comparator group to assure the patients blindness

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Masking description

Participant masking as patients will be divided into two groups High frequecy cerebellar repetitive transcranial magnetic stimulation and Sham repetitive transcranial magnetic stimulation by placing the coil in perpendicular way away from the cerebellum. Care provider masking as the physical therapist treating patients will be blind from the application of repetitive transcranial magnetic stimulation

Eligibility

Sex/Gender
ALL
Age
20 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Clinically definite MS (relapsing, remitting and secondary progressive) patients * Patients who are medically stable and Free from relapses three months before * Ambulant patients without an assistive device and score less than 5 on the Kurtzke Expanded Disability Status Scale (EDSS) * Patients receiving their disease modifying drugs but no medication changing during the previous three months. * Patients who had MRI evidence of lesions in the cerebellum or in the cerebellar pedunculi. * Right handed patients. * Severity of ataxia range from 4 to 10 according to scale of assessment and rating ataxia (SARA). * Did not apply cerebellar transcranial magnetic stimulation before.

Exclusion criteria

* Any other neurological deficits or orthopedics abnormalities. * Ataxic manifestations for other cause rather than Multiple Sclerosis. * Other neurological manifestations (e.g. spasticity, visual loss) * Secondary musculoskeletal complication such as contractures or deformities. Cardiovascular, pulmonary, hepatic, renal, hemopoietic and thyroid diseases. * Pregnant women. * Addicted individuals. * Previous surgeries in the brain. * Any magnetic or metallic devices implanted (like cochlear implants) . * Psychotic deficits or history of epileptic seizures.

Design outcomes

Primary

MeasureTime frameDescription
Biodex balance system2 weeks after end of treatmentChange of balance and stability index from baseline to 2 weeks after the beginning of intervention (when the score decreases, this means good)

Secondary

MeasureTime frameDescription
Berg balance scale2 weeks after end of treatmentChange of the balance score from baseline to two weeks after the beginning of the intervention ( the scale consists of 14 item. Minimum score for each item is 0 and maximum score is 4, to record the patient the summation of the 14 item is counted. And if the score is increasing this means good)
Nine-Hole Peg Test (9-HPT)2 weeks after end of treatmentChange of manual dexterity of both the dominant and non dominant hand from baseline to 2 weeks after the beginning of intervention
Four square step test (FSST)2 weeks after end of treatmentChange of dynamic balance and coordination from baseline to 2 weeks after the beginning of intervention

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026